Skip to Content

TOWA Pharmaceutical Co Ltd TWAPF Stock Quote

| Rating as of


Market Closed

Chart Data Not Available

No price data available

  • Last Close 24.35
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Blend
  • Day Range 24.35  –  24.35
  • Year Range 24.35  –  24.35
  • Market Cap 1.1984 Bil
  • Volume / Avg 186.0 /  186.0
  • Price / Sales 0.83
  • Price / Book 1.06
  • Forward Div Yield 1.79%
  • Trailing Div Yield 180.70%

Morningstar‘s Stock Analysis TWAPF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics TWAPF

Company Profile TWAPF

Business Description

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

2-11, Shinbashi-cho, Kadoma
Osaka, 571-8580, JPN
Industry Drug Manufacturers - Specialty & Generic
Employees 5,135

Competitors & Peers TWAPF

Morningstar does not cover competitors or peers for this firm.

FAQs for TOWA Pharmaceutical Co Ltd Stock

Yes. TWAPF has a forward dividend yield of 1.79%. See TWAPF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

TWAPF’s market cap is 1.20 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

TWAPF’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

TWAPF’s price/sales is 0.83.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

TWAPF’s price/forward earnings is 6.99.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

TWAPF’s price/book is 1.06.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See TWAPF’s valuation ratios compared to the Market Index.

TWAPF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare TWAPF’s historical performance against its industry peers and the overall market.